Roche sells Italian formulations plant to CMO Delpharm
Delpharm has been contracted to make solid and liquid forms for Roche after buying the facility in Milan.
Archives for September 5, 2017
Asia-based CRO group secures investment from private equity
TPG has acquired a majority stake in the OPC Holding Company – a network of companies providing services across the clinical development pipeline.
Pharma Finance
Mid-size CRO market update: battle for customers is heating up
The mid-size contract research organization (CRO) sector continues to evolve and surprise experts with rich valuations – and what seems to be a never ending list of transactions.
Oramed looking for commercialisation partner for oral insulin in US
Oramed is eying up commercial partnerships for its oral insulin candidate following a positive meeting with the US FDA to discuss an appropriate approval pathway.
Asian innovation: Big Pharma’s push to modernise manufacturing
Pfizer, Merck & Co (known as MSD outside of North America) and GlaxoSmithKline (GSK) have come together to support the development of continuous manufacturing and bio-catalysis technologies in Singapore.
‘Refreshed with capital’ AMRI eyes acquisitions, looks to double revenue
AMRI has been acquired by a private equity firm and has already begun its search for “the next couple of acquisitions,” says its CEO – and the shopping list is long.